Brincidofovir - Generic Drug Details

What are the generic drug sources for brincidofovir and what is the scope of freedom to operate?

Brincidofovir is the generic ingredient in one branded drug marketed by Emergent Biodefense and is included in two NDAs. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Brincidofovir has forty-six patent family members in fifteen countries.

One supplier is listed for this compound.

Summary for brincidofovir

International Patents:	46
US Patents:	5
Tradenames:	1
Applicants:	1
NDAs:	2
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	29
Clinical Trials:	19
Patent Applications:	561
What excipients (inactive ingredients) are in brincidofovir?	brincidofovir excipients list
DailyMed Link:	brincidofovir at DailyMed

Recent Clinical Trials for brincidofovir

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
SymBio Pharmaceuticals	Phase 2
SymBio Pharmaceuticals	Phase 1
Food and Drug Administration (FDA)	Phase 2

See all brincidofovir clinical trials

US Patents and Regulatory Information for brincidofovir

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Emergent Biodefense	TEMBEXA	brincidofovir	SUSPENSION;ORAL	214460-001	Jun 4, 2021		RX	Yes	Yes
Emergent Biodefense	TEMBEXA	brincidofovir	SUSPENSION;ORAL	214460-001	Jun 4, 2021		RX	Yes	Yes			Y	Y
Emergent Biodefense	TEMBEXA	brincidofovir	TABLET;ORAL	214461-001	Jun 4, 2021		RX	Yes	Yes			Y
Emergent Biodefense	TEMBEXA	brincidofovir	TABLET;ORAL	214461-001	Jun 4, 2021		RX	Yes	Yes			Y	Y
Emergent Biodefense	TEMBEXA	brincidofovir	TABLET;ORAL	214461-001	Jun 4, 2021		RX	Yes	Yes
Emergent Biodefense	TEMBEXA	brincidofovir	TABLET;ORAL	214461-001	Jun 4, 2021		RX	Yes	Yes
Emergent Biodefense	TEMBEXA	brincidofovir	TABLET;ORAL	214461-001	Jun 4, 2021		RX	Yes	Yes			Y	Y

International Patents for brincidofovir

Country	Patent Number	Title	Estimated Expiration
European Patent Office	3020720	DÉRIVÉS ESTERS PHOSPHONATES ET LEURS PROCÉDÉS DE SYNTHÈSE (PHOSPHONATE ESTER DERIVATIVES AND METHODS OF SYNTHESIS THEREOF)
Israel	245576	צורות מורפיות של הקסאדציקלוקסיפרופיל-פוספונאט אסטרים (Morphic forms of hexadecyloxypropyl-phosphonate esters)
Russian Federation	2581045	ПРОИЗВОДНЫЕ ЭФИРОВ ФОСФОНОВЫХ КИСЛОТ И СПОСОБЫ ИХ СИНТЕЗА (PHOSPHONIC ACID ESTERS AND METHODS FOR SYNTHESIS THEREOF)
South Korea	101812433
Eurasian Patent Organization	201691006	МОРФОЛОГИЧЕСКИЕ ФОРМЫ ГЕКСАДЕЦИЛОКСИПРОПИЛОВЫХ СЛОЖНЫХ ЭФИРОВ ФОСФОНОВОЙ КИСЛОТЫ И СПОСОБЫ ИХ СИНТЕЗА
Ukraine	116825	МОРФОЛОГІЧНІ ФОРМИ ГЕКСАДЕЦИЛОКСИПРОПІЛОВИХ СКЛАДНИХ ЕФІРІВ ФОСФОНОВОЇ КИСЛОТИ І СПОСОБИ ЇХ СИНТЕЗУ (MORPHIC FORMS OF HEXADECYLOXYPROPYL-PHOSPHONATE ESTERS)
Canada	2809679	DERIVES ESTERS PHOSPHONATES ET LEURS PROCEDES DE SYNTHESE (PHOSPHONATE ESTER DERIVATIVES AND METHODS OF SYNTHESIS THEREOF)